Skip to main content
Log in

Patienten mit diffus großzelligem B-Zell-Lymphom

PET/CT-gesteuerte Therapie im Stadium I/II

  • Journal club
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur:

  1. Pfreundschuh MG et al. Lancet Oncol. 2006;7(5):379-91

  2. Stephens DM. et al. J Clin Oncol. 2016;34(25):2997-3004

  3. Persky DO et al. Blood. 2015;125(2):236-41

  4. Sehn LH et al. Annals of Oncol. 2011;22(Suppl_4):Iv91

  5. Jais JP et al. Haematologica. 2017;102(10):e404-e406

  6. Poeschel V et al. Blood. 2018;132(Suppl_1):781

  7. Persky D et al. Blood. 2019;134(Suppl_1):349

  8. Poeschel V. et al. Lancet. Lancet. 2020;394(10216):2271-81

  9. Stephens DM et al. J Clin Oncol. 2016;34(25):2997-3004

  10. Sehn LH et al. Blood. 2019;134 (Supp_1):401

  11. Mamot C et al. J Clin Oncol. 2015;33(23):2523-9

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krasniqi, F., Stenner, F. PET/CT-gesteuerte Therapie im Stadium I/II. InFo Hämatol Onkol 23, 22–23 (2020). https://doi.org/10.1007/s15004-020-8099-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-020-8099-z

Navigation